Keywords: sirion, launches, durezol, usa, therapeutics, privately-held, ophthalmic-focused

Sirion launches Durezol in USA

Article | 13 October 2008

Sirion Therapeutics, a privately-held US ophthalmic-focused biopharmaceutical firm, has launched Durezol (difluprednate ophthalmic emulsion) after it was approved by the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Difluprednate Opthalmic Emulsion

Durezol

Go to drug listing